Abstract
We read with great interest the study by Leydolt and associates 1 Leydolt C. Schriefl S. Stifter E. Haszcz A. Menapace R. Posterior capsule opacification with the iMics1 NY-60 and AcrySof SN60WF 1-piece hydrophobic acrylic intraocular lenses: 3-year results of a randomized trial. Am J Ophthalmol. 2013; 156: 375-381 Abstract Full Text Full Text PDF PubMed Scopus (30) Google Scholar investigating the long-term posterior capsular opacification (PCO) severity associated with the use of 2 acrylic hydrophobic intraocular lenses (IOL). They concluded that the differences between groups were statistically significant, which were particularly attributed to material properties and manufacturing processes. Posterior Capsule Opacification with the iMics1 NY-60 and AcrySof SN60WF 1-Piece Hydrophobic Acrylic Intraocular Lenses: 3-Year Results of a Randomized TrialAmerican Journal of OphthalmologyVol. 156Issue 2PreviewTo compare the intensity of posterior capsule opacification (PCO) 3 years after implantation of 2 different 1-piece foldable hydrophobic acrylic intraocular lenses (IOLs). Full-Text PDF ReplyAmerican Journal of OphthalmologyVol. 156Issue 6PreviewThe authors appreciate the questions posed by Drs. Carifi, Zygoura, Deshmuck, and Kopsakilis regarding the issues of capsule-optic overlap and whether intraoperative bleeding, iris trauma, or postoperative inflammation were considered as exclusion criteria.1 Full-Text PDF
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
